lobbying_activities: 3385068

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3385068	53a6259f-4e96-4b06-8a38-62e978701880	Q2	SALT POINT STRATEGIES	401105514	VERTEX PHARMACEUTICALS	2025	second_quarter	PHA	Non-opioid pain relief and drug pipeline issues.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2025-07-16T13:14:32-04:00